Global Hyperthermia Cancer Treatment Market Insights Forecasts to 2033

• The Global Hyperthermia Cancer Treatment Market Size was Valued at USD 187.03 Million in 2023
• The Market Size is Growing at a CAGR of 6.03% from 2023 to 2033
• The Worldwide Hyperthermia Cancer Treatment Market Size is Expected to Reach USD 336.01 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Hyperthermia Cancer Treatment Market Size is Anticipated to Exceed USD 336.01 Million by 2033, Growing at a CAGR of 6.03% from 2023 to 2033.

Market Overview

Hyperthermia is a new type of therapy for cancer treatment. Hyperthermia treatment uses heat to inhibit cancer cells and shrink tumors. In hyperthermia treatment, body tissue is heated to as high as 1130 to destroy and inhibit cancer cells with less or no harm to normal tissue. Hyperthermia cancer treatment is also known as thermal therapy, thermotherapy, and thermal ablation. There are various types of techniques used to produce heat for hyperthermia treatment, including radio waves, lasers, probes that make energy from microwaves, and ultrasound. Hyperthermia therapy can also be used in other cancer treatments to make it more effective, along with radiation therapy and chemotherapy. It has been used to treat various types of advanced cancers, such as bladder cancer, breast cancer, head and neck cancer, appendix cancer, liver cancer, esophageal cancer, brain cancer, melanoma, sarcoma, and lung cancer. There are various types of hyperthermia cancer treatment, like local hyperthermia therapy, regional hyperthermia therapy, and whole-body hyperthermia therapy. The market for hyperthermia-induced cancer treatments is driven by the need for sophisticated cancer therapies and the potential for hyperthermia to enhance the efficacy of chemotherapy and radiation therapy. Advanced technology and clinical evidence supporting its benefits in specific cancer types further expand the market.

Report Coverage

This research report categorizes the market for the global hyperthermia cancer treatment market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global hyperthermia cancer treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global hyperthermia cancer treatment market.

Driving Factors

Increasing cases of various types of cancer, like breast cancer, cervical cancer, skin cancer, and prostate cancer, is a key factor driving the hyperthermia cancer treatment market. The growing number of cancer patients is driving up demand for cutting-edge and successful cancer treatment techniques like hyperthermia therapy. Hyperthermia is probably used with chemotherapy and radiation therapy to enhance results. The rising disease burden is driving the acquisition of hyperthermia devices. Additionally, there is rising awareness among oncologists and patients regarding the capability of hyperthermia therapy to improve the effects of chemotherapy and radiation therapy. Considerable research validating the advantages of hyperthermia and its capability to improve tumor oxygenation is propelling its adoption in clinical settings. Furthermore, the key players in the hyperthermia cancer treatment market are constantly launching advanced devices to strengthen their product portfolio.

Restraining Factors

Hypothermia therapy involves high expenses ranging from US$150,000 to US$500,000. Additional costs are sustained for yearly maintenance contracts. Lack of awareness and the absence of reimbursement for hyperthermia therapy in some countries have restrained acquisition by small clinics and hospitals with budget limitations. Furthermore, the procedure requires skilled oncologists, technicians, physicians, and nurses trained in operating and maintaining the hyperthermia device. The absence of expertise in operating safe and effective hyperthermia procedures has negatively impacted acquisition. In addition, the adverse effects of hyperthermia, such as significant pain, skin burns, and discomfort, have limited its acquisition for cancer treatment. These factors have restrained the growth of the hyperthermia cancer treatment market.

Market Segmentation

The global hyperthermia cancer treatment market share is classified into device type, application, and end-user.

• The microwave hyperthermia device segment is anticipated to hold the largest share of the global hyperthermia cancer treatment market during the forecast period.    

On the basis of the device type, the global hyperthermia cancer treatment market is divided into infrared hyperthermia device, ultrasound hyperthermia device, microwave hyperthermia device, and short-wave hyperthermia device. Among these, the microwave hyperthermia device segment is anticipated to hold the largest share of the global hyperthermia cancer treatment market during the forecast period. As per the latest research, the urge remains high for microwave devices on the market. This is due to the fact that these devices provide a diversity of heating approaches that can treat most of the cancers, despite their size. These devices are broadly used as a supplement therapy for cancer treatment. This is because they can notably enhance the effectiveness of other cancer treatments, such as chemotherapy and radiotherapy.

• The breast cancer segment is anticipated to hold the highest share of the global hyperthermia cancer treatment market during the forecast period.    

On the basis of the application, the global hyperthermia cancer treatment market is divided into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumor, and prostate cancer. Among these, the breast cancer segment is anticipated to hold the highest share of the global hyperthermia cancer treatment market during the forecast period. Increasing cases of breast cancer worldwide are a major factor predicted to boost the target segment. Similarly, the rising popularity of hyperthermia therapy for treating breast cancer patients can ease the segment. According to the International Agency for Research on Cancer (IARC), breast cancer weight is predicted to rise to more than 3 million new cases per year by 2040. This is anticipated to boost demand for hyperthermia treatments as well as heat treatment equipment, thus propelling segment growth.    

• The hospitals segment is anticipated to hold the largest share of the global hyperthermia cancer treatment market during the forecast period.  

 On the basis of end-user, the global hyperthermia cancer treatment market is divided into hospitals, clinics, research institutes, and cancer centers. Among these, the hospitals segment is anticipated to hold the largest share of the global hyperthermia cancer treatment market during the forecast period. This is due to the increasing number of hospitals worldwide, growing patient footfall, and the availability of advanced infrastructure in hospitals. Patients usually choose cancer diagnostic methods and treatments in hospitals due to the cost-effectiveness and availability of advanced technologies and healthcare professionals. Thus, several hospitals are incorporating advanced hyperthermia systems, propelling segment growth.

Regional Segment Analysis of the Global Hyperthermia Cancer Treatment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global hyperthermia cancer treatment market over the predicted timeframe.

North America is anticipated to hold the largest share of the global hyperthermia cancer treatment market over the predicted timeframe. These regions are distinguished by advanced healthcare facilities, a strong focus on research and development, and the presence of key medical device manufacturers. In North America, the US represents the supreme market, propelled by factors like a well-developed healthcare system, a high rate of cancer, and the availability of inventive hyperthermia treatment technologies. The region’s importance to treatment approaches has contributed significantly to its market share.

Asia-Pacific is anticipated to grow at the fastest rate in the global hyperthermia cancer treatment market over the predicted timeframe. This region’s importance can be attributed to several factors, such as its large population base, the rising cases of cancer, and the increasing acquisition of advanced cancer technologies. Countries like China, Japan, and South Korea are propelling the demand for hyperthermia cancer treatment solutions in the Asia-Pacific region. The region’s focus on enhancing healthcare facilities, the availability of trained medical professionals, and rising awareness regarding alternative cancer treatment options have contributed to the growth of the hyperthermia cancer treatment market over the predicted timeframe.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global hyperthermia cancer treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Andromedic S.r.l.
• Oncotherm Kft
• YAMAMOTO VINITA CO., LTD
• Alba Hyperthermia System
• Sensius
• MagForce AG
• Celsius42 GmbH
• Pyrexar Medical
• Nanoprobes
• Novavida
• Hydrosun GmbH
• Chongqing Haifu Medical Technology Co., Ltd.
• RanD
• Gamida
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In April 2023, Pyrexar Medical declares the CE mark renewal of its product line of RF Hyperthermia systems, involving the BSD-2000 3D/MR Deep Regional Hyperthermia System and the BSD-500 Superficial-Interstitial Hyperthermia System, among others.

• In August 2022, a novel Tumor Hyperthermia center was established in China that can use the Pyrexar BSD-2000 Deep Regional Hyperthermia System. This advanced hyperthermia system can be used to treat cancer tumors and help with radiotherapy and chemotherapy treatments.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global hyperthermia cancer treatment market based on the below-mentioned segments: 

Global Hyperthermia Cancer Treatment Market, By Device Type

• Infrared Hyperthermia Device
• Ultrasound Hyperthermia Device
• Microwave Hyperthermia Device
• Short-wave Hyperthermia Device

Global Hyperthermia Cancer Treatment Market, By Application

• Breast Cancer
• Liver Cancer
• Soft Tissue Sarcoma
• Head & Neck Tumor
• Prostate Cancer

Global Hyperthermia Cancer Treatment Market, By End-User

• Hospitals
• Clinics
• Research Institutes
• Cancer Centers

Global Hyperthermia Cancer Treatment Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa